Almoosa Health Company Cash Flow Statement

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	200.4	94.42	98.15	51.02	62.42
Depreciation & Amortization	-	81.73	64.76	56.94	28.49
Other Amortization	-	2.62	3.53	2.65	1.46
Loss (Gain) From Sale of Assets	-	-0.11	-0.33	-0.03	0.07
Asset Writedown & Restructuring Costs	-	-	-	0.01	0.01
Loss (Gain) on Equity Investments	-	-1.19	-	-	-
Provision & Write-off of Bad Debts	-	4.41	3.93	-0.17	1.22
Other Operating Activities	10.3	25.38	10.36	14.93	12.08
Change in Accounts Receivable	-	-42.3	-166.81	-66.22	-10.71
Change in Inventory	-	-8.81	-9.29	-0.16	-7.77
Change in Accounts Payable	-	42.92	3.15	-49.76	75.25
Change in Other Net Operating Assets	-	-15.38	32.62	-20.19	35.21
Operating Cash Flow	210.7	183.68	40.07	-10.97	197.72
Operating Cash Flow Growth	14.71%	358.41%	-	-	31.88%
Capital Expenditures	-	-240.34	-383.19	-307.18	-318.47
Sale of Property, Plant & Equipment	-	1.36	23.07	0.03	0.02
Sale (Purchase) of Intangibles	-	-6.33	-2.16	-2.89	-0.31
Sale (Purchase) of Real Estate	-	-16.93	-92.1	-	-
Investment in Securities	-	-	-	-	3.28
Other Investing Activities	-646.9	-	-	-	-
Investing Cash Flow	-646.9	-262.23	-454.39	-310.04	-315.49
Long-Term Debt Issued	-	305.59	622.91	285.67	148.91
Long-Term Debt Repaid	-	-190.67	-208	-7.54	-7.54
Total Debt Repaid	-	-190.67	-208	-7.54	-7.54
Net Debt Issued (Repaid)	-	114.92	414.92	278.13	141.38
Common Dividends Paid	-	-14.01	-	-	-15.66
Other Financing Activities	436.3	-	-	-	-
Financing Cash Flow	436.3	100.92	414.92	278.13	125.71
Net Cash Flow	0.1	22.36	0.6	-42.88	7.94
Free Cash Flow	210.7	-56.66	-343.12	-318.15	-120.76
Free Cash Flow Margin	14.88%	-4.71%	-35.05%	-38.99%	-17.21%
Free Cash Flow Per Share	4.73	-1.62	-9.80	-9.09	-1207.55
Cash Interest Paid	-	78.55	24.02	10	1.14
Levered Free Cash Flow	0.81	-112.73	-369.73	-359.89	-122.63
Unlevered Free Cash Flow	15.81	-63.42	-357.82	-351.6	-121.7
Change in Working Capital	-	-23.57	-140.33	-136.33	91.98

Source: S&P Global Market Intelligence. Standard template. Financial Sources.